Implications of mRNA-based SARS-CoV-2 vaccination for cancer patients.

Journal for Immunotherapy of Cancer
Emanuela RomanoPatrick Ott

Abstract

SARS-CoV-2 infection and the resulting COVID-19 have afflicted millions of people in an ongoing worldwide pandemic. Safe and effective vaccination is needed urgently to protect not only the general population but also vulnerable subjects such as patients with cancer. Currently approved mRNA-based SARS-CoV-2 vaccines seem suitable for patients with cancer based on their mode of action, efficacy, and favorable safety profile reported in the general population. Here, we provide an overview of mRNA-based vaccines including their safety and efficacy. Extrapolating from insights gained from a different preventable viral infection, we review existing data on immunity against influenza A and B vaccines in patients with cancer. Finally, we discuss COVID-19 vaccination in light of the challenges specific to patients with cancer, such as factors that may hinder protective SARS-CoV-2 immune responses in the context of compromised immunity and the use of immune-suppressive or immune-modulating drugs.

References

Feb 11, 1998·Clinical Microbiology Reviews·L A Pirofski, A Casadevall
Jul 2, 1999·British Journal of Cancer·H AndersonM Zambon
Jan 9, 2001·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·L B BrydakS S Góźdź
Nov 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ramesh K RamanathanDonald L Trump
Jul 23, 2004·Expert Opinion on Biological Therapy·Steve Pascolo
Sep 20, 2005·Cancer Treatment Reviews·David AzriaMahmut Ozsahin
Nov 24, 2005·Clinical Medicine & Research·Joseph J MazzaKurt D Reed
Oct 7, 2006·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Abigail L SommerJudith A Smith
Dec 12, 2007·Handbook of Experimental Pharmacology·Steve Pascolo
May 16, 2008·Journal of Immunotherapy·Benjamin WeideSteve Pascolo
Jul 30, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P LoulergueO Launay
Oct 29, 2009·Bone Marrow Transplantation·P LjungmanUNKNOWN Centers for Disease Control and Prevention
Nov 4, 2010·The Oncologist·Howard A Burris, Jane Hurtig
Dec 21, 2010·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Helen J MackayAmit M Oza
Dec 30, 2010·Molecular Therapy : the Journal of the American Society of Gene Therapy·Susanne M RittigPeter Brossart
Jan 15, 2015·Expert Review of Vaccines·Steve Pascolo
Aug 16, 2017·Proceedings of the National Academy of Sciences of the United States of America·Jesper PallesenJason S McLellan
Apr 15, 2018·Proceedings of the National Academy of Sciences of the United States of America·Eunseon AhnRafi Ahmed
Feb 13, 2019·The Lancet Infectious Diseases·Catherine CordonnierUNKNOWN European Conference on Infections in Leukaemia group
Nov 5, 2019·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Bhumsuk KeamMyoung-Don Oh
Mar 20, 2020·Science Translational Medicine·Cornelis J M MeliefSjoerd H van der Burg
Apr 17, 2020·British Journal of Haematology·Vanessa Cui Lian ChongPonnudurai Kuperan
Jun 1, 2020·Lancet·Nicole M KudererUNKNOWN COVID-19 and Cancer Consortium
Jun 2, 2020·The Journal of Infectious Diseases·Chang Kyung KangMyoung-Don Oh
Jul 16, 2020·ERJ Open Research·Eleni PapoutsiParaskevi Katsaounou
Sep 15, 2020·Oncoimmunology·Mathias VormehrÖzlem Türeci
Dec 11, 2020·The New England Journal of Medicine·Fernando P PolackUNKNOWN C4591001 Clinical Trial Group
Dec 31, 2020·The New England Journal of Medicine·Lindsey R BadenUNKNOWN COVE Study Group
Feb 6, 2021·Nature·Steven A KempRavindra K Gupta
Feb 11, 2021·Nature·Zijun WangMichel C Nussenzweig

❮ Previous
Next ❯

Software Mentioned

BioRender
Moderna

Related Concepts

Related Feeds

Cancer Immunotherapy

Cancer immunotherapy is an important field of research that is looking at controlling cancer and tumor growth by activating the individuals own immune system. Recent studies have utilized chimeric antigen receptor t-cell therapy, immune checkpoint inhibitors and neoantigen vaccines. Discover the latest research on cancer immunotherapy here.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Related Papers

Transplant Infectious Disease : an Official Journal of the Transplantation Society
Aris TsalouchosPietro Claudio Dattolo
MedRxiv : the Preprint Server for Health Sciences
Emily J CicconeAllison E Aiello
Clinics and Research in Hepatology and Gastroenterology
Jérôme Dumortier
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
Fuzhou WangGeorge B Stefano
© 2021 Meta ULC. All rights reserved